Early Detection and Management of Hearing Loss to Reduce Dementia Risk
Key Findings from the TACT Trial
Background: Hearing loss and mild cognitive impairment (MCI) both increase the risk of dementia in older adults. A previous study showed that hearing aids can help slow cognitive decline in older adults with hearing issues.
Methods: This pilot study involved older adults (aged 55 and above) with untreated hearing loss. Participants were divided into two groups: one received hearing aids and support, while the other received education on healthy aging and a referral for hearing tests. They were monitored for 6 months.
Results: A total of 58 participants joined the study. The group receiving hearing aids had a significantly higher fitting rate (83%) compared to the control group (21%). After 6 months, 75% of those with hearing aids used them daily, compared to only 22% in the control group.
Conclusion: The study shows that it is feasible to provide personalized hearing interventions to older adults with MCI. These promising results support further research with larger trials.
Value of Clinical Trials
Clinical trials are essential for developing safe and effective treatments. To make these benefits accessible in everyday healthcare, we offer DocSym, an AI-driven platform that combines clinical standards and research into a user-friendly resource for healthcare providers.
Practical Solutions for Healthcare
In today’s healthcare landscape, efficiency is key. Our mobile apps facilitate scheduling, treatment monitoring, and telemedicine, enhancing patient care management and digital service delivery.
By leveraging AI, clinics can streamline their operations, improve patient outcomes, and reduce paperwork. Discover how we can assist you at aidevmd.com.
